FRANKFURT (Reuters) - German drugmaker Bayer AG said on Wednesday it was cleared by the French health authority to reintroduce oral acne treatment Diane-35 to the French market after an eight-month suspension.
The European Commission said in July that Diane-35 was safe for use, a seal of approval which obliged France to allow sales of the product again.
France had suspended sales of Diane-35 after four deaths over the past 25 years were linked to its use.
The pill reduces acne by regulating hormones and blocking ovulation, and is often prescribed as a contraceptive even though it is not approved for this use.
Reporting by Ludwig Burger; Editing by Christoph Steitz